To explore the relationship between the anti-atherosclerosis effect of selegiline and gut microbiota, 16S rRNA sequencing was used to observe the changes in gut microbiota in HFD-fed ApoE−/− mice treated with selegiline. The gene discussed is APOE; the disease is atherosclerosis.